Chicago Equity Partners LLC boosted its stake in ICU Medical, Incorporated (NASDAQ:ICUI) by 48.4% during the 3rd quarter, HoldingsChannel reports. The fund owned 11,970 shares of the medical instruments supplier’s stock after buying an additional 3,905 shares during the period. Chicago Equity Partners LLC’s holdings in ICU Medical were worth $3,385,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently bought and sold shares of the company. Cerebellum GP LLC acquired a new stake in ICU Medical in the third quarter valued at $186,000. Mackay Shields LLC acquired a new stake in ICU Medical in the second quarter valued at $205,000. CIBC Asset Management Inc acquired a new stake in ICU Medical in the second quarter valued at $209,000. LPL Financial LLC acquired a new stake in shares of ICU Medical during the first quarter worth $218,000. Finally, First Hawaiian Bank acquired a new stake in shares of ICU Medical during the third quarter worth $226,000. 73.51% of the stock is currently owned by hedge funds and other institutional investors.
A number of analysts have weighed in on the stock. Zacks Investment Research cut shares of ICU Medical from a “buy” rating to a “hold” rating in a report on Saturday. ValuEngine cut shares of ICU Medical from a “buy” rating to a “hold” rating in a report on Tuesday. BidaskClub cut shares of ICU Medical from a “buy” rating to a “hold” rating in a report on Thursday. Finally, TheStreet raised shares of ICU Medical from a “c+” rating to a “b+” rating in a report on Monday, August 20th.
ICU Medical (NASDAQ:ICUI) last issued its earnings results on Thursday, November 8th. The medical instruments supplier reported $1.85 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.51 by $0.34. The company had revenue of $327.20 million for the quarter, compared to analysts’ expectations of $334.97 million. ICU Medical had a net margin of 5.93% and a return on equity of 12.78%. The firm’s revenue was down 4.7% compared to the same quarter last year. During the same period in the prior year, the company earned $1.12 earnings per share. Sell-side analysts anticipate that ICU Medical, Incorporated will post 7.6 EPS for the current fiscal year.
In other ICU Medical news, VP Thomas D. Mccall sold 11,133 shares of the stock in a transaction on Friday, August 24th. The shares were sold at an average price of $302.56, for a total transaction of $3,368,400.48. Following the sale, the vice president now directly owns 3,018 shares of the company’s stock, valued at $913,126.08. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Pfizer Inc sold 700,000 shares of the company’s stock in a transaction dated Monday, August 13th. The stock was sold at an average price of $284.35, for a total transaction of $199,045,000.00. The disclosure for this sale can be found here. Insiders have sold 711,920 shares of company stock worth $202,651,956 over the last three months. 12.50% of the stock is owned by corporate insiders.
ICU Medical Company Profile
ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.
Featured Article: What is intrinsic value?
Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Incorporated (NASDAQ:ICUI).
Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.